News
12-11-2014, 02:14 AM
A new combination of cancer drugs delayed disease progression for patients with hormone-receptor-positive metastatic breast cancer, according to a multi-center phase II trial. The findings of the randomized study (S6-03) were presented at the 2014 San Antonio Breast Cancer Symposium, held Dec. 6-9, by Kerin Adelson, M.D., assistant professor of medical oncology at Yale Cancer Center and chief quality officer at Smilow Cancer Hospital at Yale-New Haven.
More... (http://www.news-medical.net/news/20141211/Drugs-delay-disease-progression-for-women-with-hormone-receptor-positive-metastatic-breast-cancer.aspx)
More... (http://www.news-medical.net/news/20141211/Drugs-delay-disease-progression-for-women-with-hormone-receptor-positive-metastatic-breast-cancer.aspx)